The Parents Coalition for Rescheduling Medical Cannabis endorses the Charlotte's Web Medical Hemp Act (H.R. 5226) of 2014, which removes therapeutic hemp from the Controlled Substances Act.
This legislation resolves legal ambiguity, allowing the production of therapeutic hemp in the United States. This would increase supply, improving access and affordability.
While the Parents Coalition recommends all cannabis be rescheduled for medicinal purpose, H.R. 5226 would allow immediate access to therapeutic hemp for many with serious health conditions.
Where state laws permit, this bill would allow patients to cross state lines with their treatment, enabling families who moved across country for CBD oil to return home without risking prosecution.
Since the Parents Coalition represents families from across the country that helped pass legislation in home states, and some still trying, we understand laws change slowly and that progress is a gradual process. Though limited, this legislation is an important first step for improving access and quality of life. Our work continues until all cannabis strains are removed from Schedule 1 of the Controlled Substances Act, so medical research flourishes in the United States and patients have compassionate access.
About the Parents Coalition for Rescheduling Medical Cannabis
We are parents of children with epilepsy, autism, and other serious conditions potentially treatable by therapeutic hemp and medical cannabis. Many of us helped legalize strains in home states only to have our children's access stymied by federal restrictions. In 2014 we joined forces nationally, urging the federal government to remove hemp and cannabis from its list of banned Schedule 1 substances. Rescheduling or other reclassification of these plants would foster patient access and hasten medical research.